Suppr超能文献

[远程缺血预处理对慢性完全闭塞患者经皮冠状动脉介入术后造影剂诱导的急性肾损伤的影响]

[Effects of remote ischemic preconditioning on contrast-induced acute kidney injury after percutaneous coronary intervention in patients with chronic total occlusion].

作者信息

Yan G L, Yang M M, Zuo P F, Wang D, Chen L, Li Y J, Chen L J, Feng Y, Tang C C, Ma G S

机构信息

Department of Cardiology, Zhongda Hospital, Medical School of Southeast University, Nanjing 210009, China.

出版信息

Zhonghua Yi Xue Za Zhi. 2021 Mar 23;101(11):776-781. doi: 10.3760/cma.j.cn112137-20200627-01955.

Abstract

To investigate the effect of remote ischemic preconditioning (RIPC) on contrast-induced acute kidney injury (CI-AKI) in patients with chronic total occlusion (CTO) after percutaneous coronary intervention (PCI). A total of 282 patients undergoing PCI at Zhongda Hospital Affiliated to Southeast University between June 2017 and January 2019 were prospectively enrolled. The patients were randomly divided into RIPC group (=142) and control group (=140). CI-AKI was defined as an increase in level of cystatin C (CysC)≥10% above baseline at 24 h after contrast administration. Baseline characteristics and the incidence of CI-AKI were compared between the two groups. The multivariate logistic regression analysis was further used to analyze the independent risk factors of CI-AKI. There were no significant differences in age, gender, smoking, hypertension, diabetes, stroke and old myocardial infarction, coronary artery bypass graft surgery, previous PCI history and laboratory test indicators, target vessel and pathological characteristics of CTO lesions, contrast agent dosage, J-CTO (Multicenter CTO Registry in Japan) score, SYNTAX (Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) score, PCI success rate and stent number between the two groups (>0.05). The incidence of CI-AKI was significantly lower (18.3% vs 29.3%, =0.036) in RIPC group than that of control group. Multivariate logistic analysis found that creatinine [odds ratio ()=1.018,95%: 1.006-1.030, =0.003], CysC (=5.200, 95%:2.714-9.963, 0.001),contrast agent dosage (=1.013,95%: 1.007-1.019, 0.001) and J-CTO score (=1.834, 95%: 1.145-2.939, =0.012) were independent risk factors of CI-AKI. However, RIPC was an independent protective factor of CI-AKI (=0.391, 95%: 0.199-0.765, =0.006). RIPC before contrast agent administration prevents CI-AKI in CTO patients undergoing PCI.

摘要

探讨远程缺血预处理(RIPC)对慢性完全闭塞(CTO)患者经皮冠状动脉介入治疗(PCI)后造影剂诱导的急性肾损伤(CI-AKI)的影响。前瞻性纳入2017年6月至2019年1月在东南大学附属中大医院接受PCI的282例患者。患者被随机分为RIPC组(=142)和对照组(=140)。CI-AKI定义为造影剂注射后24小时胱抑素C(CysC)水平较基线升高≥10%。比较两组的基线特征和CI-AKI的发生率。进一步采用多因素logistic回归分析CI-AKI的独立危险因素。两组在年龄、性别、吸烟、高血压、糖尿病、中风和陈旧性心肌梗死、冠状动脉搭桥手术、既往PCI史和实验室检查指标、靶血管和CTO病变的病理特征、造影剂用量、J-CTO(日本多中心CTO注册研究)评分、SYNTAX(紫杉醇药物洗脱支架与心脏外科手术协同作用)评分、PCI成功率和支架数量方面无显著差异(>0.05)。RIPC组CI-AKI的发生率显著低于对照组(18.3%对29.3%,=0.036)。多因素logistic分析发现,肌酐[比值比(OR)=1.018,95%可信区间:1.006-1.030,=0.003]、CysC(=5.200,95%可信区间:2.714-9.963,=0.001)、造影剂用量(=1.013,95%可信区间:1.007-1.019,=0.001)和J-CTO评分(=1.834,95%可信区间:1.145-2.939,=0.012)是CI-AKI的独立危险因素。然而,RIPC是CI-AKI的独立保护因素(=0.391,95%可信区间:0.199-0.765,=0.006)。造影剂注射前进行RIPC可预防CTO患者PCI术后发生CI-AKI。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验